News
News
- PTA-News: Medigene AG: Medigene AG Announces Appointment of Dr. Kirsty Crame, MD, as Head of Clinical Research & Development
03/20/2023 / 11:00 - pressetext - PTA-News: 4SC AG: 4SC AG provides results for financial year 2022 and outlook for 2023
03/17/2023 / 07:30 - pressetext - PTA-News: Medigene AG: Medigene to present first pre-clinical data for MDG1015 with poster presentation at AACR 2023 Annual Meeting
03/16/2023 / 10:00 - pressetext - PTA-News: Medigene AG: Medigene AG to report full year 2022 financial results on March 29, 2023
03/15/2023 / 16:45 - pressetext - PTA-Adhoc: Medigene AG: Medigene amends 2022 financial guidance
03/10/2023 / 18:00 - pressetext - PTA-News: Medigene AG: Medigene presents first results for automated manufacturing of T cell receptor engineered T cells
02/23/2023 / 14:00 - pressetext - PTA-News: Medigene AG: Medigene to participate in the H.C. Wainwright Cell Therapy Virtual Conference
02/22/2023 / 16:00 - pressetext - PTA-News: Medigene AG: Medigene to present at the 6th Annual CAR-TCR Summit Europe in London
02/15/2023 / 15:00 - pressetext - PTA-News: Medigene AG: Medigene AG Appoints Pamela Keck as Vice President of Investor Relations and Corporate Communications
02/01/2023 / 17:35 - pressetext - PTA-Adhoc: Medigene AG: Medigene adapts 2022 financial guidance
01/31/2023 / 17:55 - pressetext
Real-time